CAPR · NASDAQ · Biotechnology

Capricor Therapeutics

Develops deramiocel for Duchenne muscular dystrophy and StealthX exosome therapies.

$9.64
After-hours close+0.04 (+0.41%)
At close$9.60(−4.57%)
DateEstimateReportedSurprise
Nov 2026−$0.14
Aug 2026−$0.59−$0.70−18.9%
Aug 2026−$0.59−$0.70−18.9%
May 2026−$0.55−$0.59−7.3%
Mar 2026−$0.51−$0.62−21.6%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Nov 2025
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
May 2017
Mar 2017
Nov 2016
Aug 2016
May 2016
Mar 2016
Nov 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 9, 2026−$0.14$41.7M
Aug 14, 2026−$0.59−$0.70−18.9%$2.1M
Aug 13, 2026−$0.59−$0.70−18.9%$2.1M
May 12, 2026−$0.55−$0.59−7.3%$40.0M
Mar 12, 2026−$0.51−$0.62−21.6%$525.0K

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Nov 10, 2025
Aug 11, 2025
May 13, 2025
Mar 19, 2025
Nov 13, 2024
Aug 7, 2024
May 13, 2024
Feb 29, 2024
Nov 14, 2023
Aug 7, 2023
May 11, 2023
Mar 15, 2023
Nov 10, 2022
Aug 10, 2022
May 10, 2022
Mar 10, 2022
Nov 9, 2021
Aug 12, 2021
May 13, 2021
Mar 11, 2021
Nov 12, 2020
Aug 6, 2020
May 14, 2020
Mar 18, 2020
Nov 7, 2019
Aug 6, 2019
May 13, 2019
Mar 28, 2019
Nov 13, 2018
Aug 9, 2018
May 10, 2018
Mar 14, 2018
Nov 8, 2017
Aug 10, 2017
May 15, 2017
Mar 15, 2017
Nov 10, 2016
Aug 15, 2016
May 12, 2016
Mar 17, 2016
Nov 12, 2015